Centre National de la Recherche Scientifique;Universite Joseph Fourier (Grenoble 1)
发明人:
Polack, Benoit,Thomas, Aline
申请号:
AU2012223048
公开号:
AU2012223048A1
申请日:
2012.02.29
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
The invention relates to a pharmaceutical composition comprising a modified Xa factor (GDXa), said modified GDXa being non-thrombogenic and able to bind to the TFPI but not to the phospholipids, for preventing or treating a hemorrhagic accident in a patient suffering from haemophilia A or B with or without inhibitor.